SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer
Cancer Letters · 2027-01 · 664 · 218955
DOI: 10.1016/j.canlet.2026.218955 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2027-01. Verfasst von Shuwen Dong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd …. Die Arbeit nennt 52 Literaturangaben.
Abstract (Originalsprache)
Platinum-based chemotherapy is a cornerstone of triple-negative breast cancer (TNBC) treatment, yet resistance remains a significant clinical challenge. Sarcoma antigen 1 (SAGE1), a cancer-testis antigen, has been implicated in various malignancies, but its specific role in TNBC drug response and underlying mechanisms remain largely elusive. Using tumor specimens from two prospective TNBC trials, we found that high SAGE1 expression significantly correlates with inferior invasive disease-free survival in patients receiving carboplatin-containing chemotherapy. SAGE1 reduces carboplatin sensitivity in vitro and in vivo by accelerating DNA damage repair. Mechanistically, SAGE1 enhances global chromatin accessibility and H3K27ac enrichment at Fanconi Anemia (FA) pathway gene loci, interacting with p300 and BRD4 to promote H3K27ac deposition. The BET bromodomain inhibitor JQ1 reversed FA protein upregulation and restored carboplatin sensitivity in SAGE1-enriched cells. Furthermore, SAGE1 interacts with PARP1, and this interaction is associated with the regulation of PARP1 activity and with limited PARP inhibitor sensitivity. Notably, the triple combination of JQ1, carboplatin, and olaparib enhanced DNA damage and suppressed tumor growth in preclinical models. Thus, SAGE1 may contribute to an epigenetic-repair axis by facilitating chromatin opening and bolstering the FA pathway, and targeting this axis via combined carboplatin, PARP, and BET inhibition represents a promising therapeutic strategy for SAGE1-enriched TNBC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.
- Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China.
- Breast Center, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Beijing, 100142, China.
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China. Electronic address: gaoweiqi2733@163.co…
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China. Electronic address: zhengwangwilson@163…
- Department of General Surgery, Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin 2nd Road, Shanghai, 200025, China. Electronic address: kwshen@medmail.com.…
Zitieren
APA
Dong, S., Huang, R., Wang, S., Pan, R., Gao, W., Wang, Z., & Shen, K. (2027). SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer. Cancer Letters, 664, 218955. https://doi.org/10.1016/j.canlet.2026.218955
Vancouver
Dong S, Huang R, Wang S, Pan R, Gao W, Wang Z, et al. SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer. Cancer Letters. 2027;664:218955. doi:10.1016/j.canlet.2026.218955
BibTeX
@article{Dong2027,
author = {Dong, Shuwen and Huang, Renhong and Wang, Shaodong and Pan, Ruixin and Gao, Weiqi and Wang, Zheng and Shen, Kunwei},
title = {SAGE1-mediated H3K27ac enrichment promotes chromatin opening and Fanconi Anemia repair to induce carboplatin resistance in triple-negative breast cancer},
journal = {Cancer Letters},
year = {2027},
volume = {664},
pages = {218955},
doi = {10.1016/j.canlet.2026.218955}
}
EUVIMED